Aims The excretion of phospholipids in urine may be a marker of the early renal toxicity of the aminoglycoside antibiotics. Urinary phospholipids are formed in myeloid bodies which develop in the lysosomes of proximal tubules during treatment with the aminoglycosides, and overflow into the urine. Methods Published assays were modified in order to measure the total phospholipid concentrations in human urine. Phospholipids were extracted from freeze-dried urine samples, digested in concentrated sulphuric acid, and the inorganic phosphorus content determined by complexing with ammonium molybdate and measuring the absorbance at 820 nm. Ten septicaemic patients treated with gentamicin for 5-7 days had significantly higher urine phospholipid concentrations than 10 healthy untreated control subjects ( P<0.0001). There was a negative linear relationship between phospholipid excretion and creatinine clearance (r 2 =0.71). Results In 34 patients with acute pyelonephritis, increased phospholipid concentrations were observed prior to treatment compared with healthy controls (P<0.001) and did not alter during treatment with gentamicin. However, the phospholipid concentrations decreased significantly after treatment was completed ( P<0.03). Conclusions These studies suggest that urinary phospholipids may indicate early aminoglycoside toxicity but with poor specificity, as many of the infections being treated may themselves be associated with phospholipiduria.
Introduction of patients with acute pyelonephritis [8] . In a further study of four patients with various infections, the ratio of Nephrotoxicity is a significant side effect of the aminoglycoside antibiotics, with a reported incidence of up to 55% [1] .
phospholipids to protein in the urinary sediment was increased by about 30% by treatment with gentamicin [9]. The incidence, however, depends on the criteria used to define toxicity, the dosage of the aminoglycoside, and
The sedimented fraction was, however, isolated by low speed centrifugation, and probably included cells and not possibly on the specific aminoglycoside used. An increase in the serum creatinine concentration is the most commonly the lighter myeloid bodies. In view of these contrasting results, we compared the used index of aminoglycoside nephrotoxicity, but this change is insensitive and may be a late event [2] .
urinary concentrations of total phospholipids in healthy subjects, in a broad group of septicaemic patients being Administration of aminoglycosides to rats results in the development of myeloid bodies (lamellar inclusions) in the treated with gentamicin, and in patients with acute pyelonephritis before, during and after treatment with lysosomes of the proximal tubular cells of the kidney, with a lesser density in the glomerular and distal epithelium gentamicin, and in a patient who was inadvertently overdosed with gentamicin. We also report the details of the assay for [2-4]. The formation of these myeloid bodies may be associated with the development of the nephrotoxicity [2] .
the measurement of total urinary phospholipids highlighting difficulties and limitations. Although phospholipidosis in the cells and subsequent phospholipiduria are well recognised in animals, there is conflicting data in human clinical practice. One research Methods group has presented three reports showing that aminoglycosides increase the amounts of phospholipids in the sediment Materials prepared by high speed centrifugation of urine, in patients For the purpose of validation of the assay, phospholipids with urinary tract infections or pelvic inflammatory disease were obtained from Sigma Chemical Co., MO63178, USA: [5] [6] [7] . Another study, however, found that tobramycin and
, 10 m sulphuric acid (100 ml), 0.16 m Ca(NO 3 ) 2 (25 ml) and 30% hydrogen peroxide (25 ml), and heated for 20 min on (−)-a-lysophosphatidylserine [ All urine samples and standards were analysed in duplicate. and centrifuged at 4°C using a horizontal swing-out Urine samples were frozen at −35°C prior to lyophilization centrifuge (Beckman L8-70 Ultracentrifuge, 100 000 g) for and were found to be stable for at least four freeze-60 min. Tubes were carefully removed from the centrifuge thaw cycles. and the urine was then decanted, to avoid disturbing the The concentrations of creatinine in serum and urine were pellet formed by the accumulation of the myeloid bodies. measured by the Jaffe method (Canterbury Health Laboratory The resulting pellet was dispersed into 600 ml of deionised Ltd). The creatinine clearance was estimated from the serum water prior to extraction and digestion.
creatinine concentrations by the method of Cockcroft & Gault [15] as modified by Pesola et al. [16] . Extraction. Phospholipids were extracted from urine by a
The urinary phospholipid concentrations were quoted as method adapted from Folch et al. [10] and Olier et al. [8] .
their ratio compared with the urine creatinine concentration Urine lyophilizate was reconstituted and extracted as to correct for varying degrees of dilution. described by Olier et al. [8] , with the following changes. The lower CHCl 3 phase was collected and filtered through Urine specimen collection. glass wool packed into a pasteur pipette. The glass wool i ) Ten healthy volunteers (six male, four female) aged 23 filter was washed with CHCl 3 (1 ml) and finally flushed to 47 years (mean 34.3 years) provided a sample of their clean of solvent by forcing air through the filter. The urine from a single complete emptying of their bladders. combined CHCl 3 eluents were washed by vortexing with None of the healthy volunteers had a urinary tract infection 1m potassium chloride (250 ml) [10] containing 0.01% (clinically and by urine culture) or were being treated NaN 3 as an antibacterial. The mixture was then centrifuged concurrently with any drug. at 3000 g for 20 min and the CHCl 3 layer transferred to a ii ) Ten patients (all male) aged 15 to 91 years (mean 58.3 clean 100×16 mm tube. The solvent was evaporated on a years) who were hospitalised and required parenteral hot plate at 60°C under a stream of oxygen free nitrogen.
antibiotic therapy for the treatment of septicaemia, and who had a calculated creatinine clearance of greater than Digestion. Phospholipid standards and urine extracts were digested in sulphuric acid together with calcium nitrate [12] 20 ml min −1 were studied. All patients were given a single daily dose of 5-7 mg kg −1 gentamicin based on either lean and hydrogen peroxide [13] . The extracts were mixed with body weight (LBW) or actual body weight [16] , whichever by comparison with a standard curve prepared using potassium dihydrogen phosphate which required no digeswas lower, by a 30 min intravenous infusion. Doses were adjusted using the once daily gentamicin dosing method tion. The difference between the absorbances of the PC standard and phosphate was not significant. There was good described previously by Begg et al. [20] . On the fifth to seventh day of gentamicin treatment a urine sample was recovery of all the phospholipid classes at the three concentrations tested; 6.5, 19.4 and 32.3 mmol l −1 (0.2, 0.6 collected from a complete emptying of the bladder or urethral catheter drainage bag. None of the patients had a and 1 mg l −1 ). The limit of quantitation for this assay, defined as the smallest concentration with an inter-day urinary tract infection (clinically and by urine culture) or were being treated concurrently with any other potentially coefficient of variation (CV) of ≤20% (n=5), was 1.94 mmol l −1
(0.06 mg l −1 ). The average ratio of nephrotoxic drug.
iii) Thirty-four patients (four male, 30 female) aged 18 to samples assayed on two days (first determination/second determination) was 0.979 with a CV of 10.7%. 68 years (mean 32.2 years) requiring hospitalisation and parenteral antibiotic therapy for the treatment of suspected
The concentrations of phospholipids found by solvent extraction of the pellet after centrifugation of the urine of acute pyelonephritis were included in this study. Acute pyelonephritis was diagnosed if the patient had fever >37.8°C the septicaemic patients was considerably lower than the concentrations found by the solvent extraction of the together with loin pain or tenderness and infected urine. Patients were allocated to receive one of two treatment lyophilisate. The concentration found by centrifugation compared to lyophilisation was 64±11%. regimens based on a combination of gentamicin and ciprofloxacin as described in Bailey et al. [21] . One group (n=15) received a single large dose of gentamicin (10 mg kg −1 ) Urinary phospholipids followed by oral ciprofloxacin, while the other group (n=19) received conventional gentamicin therapy aiming for peaks of Healthy volunteers vs septicaemic patients. The concentrations of phospholipids in the urine of the septicaemic patients 8 and troughs of 1.5 mg l , followed by oral ciprofloxacin. The urinary phospholipids were measured predose, at 24 h, at were highly variable but the mean value was considerably higher than that of healthy subjects ( P<0.0001, Table 1 ). 3 days while receiving antibiotics, and at 1-2 weeks after the completion of the course of antibiotics.
The contrast was maintained whether the concentrations of phospholipids were considered as absolute, or relative to iv) The concentration of total urinary phospholipids was assayed in the urine of a female patient who was inadvertently urinary creatinine concentration. The two patients with the highest serum concentrations of creatinine (and the lowest overdosed with 240 mg gentamicin every 4 h (instead of once daily) for 16 h. creatinine clearances) also had the highest concentrations of phospholipids in urine, although one patient with a very All study protocols were approved by the Southern Regional Health Authority (Canterbury) ethics committee.
high phospholipid concentration ratio (4.59 mmol mol −1 creatinine) had a normal serum creatinine concentration All subjects gave written consent prior to urine samples being taken.
( Table 1 ). There was a linear negative relationship between the calculated creatinine clearance and the extent of phospholipid excretion in the 10 patients with septicaemia Statistical analysis The Mann-Whitney U-test was used to test the following (Figure 1 ) (r 2 =0.71). in relation to phospholipid excretion: the difference between healthy controls and the 10 septicaemic patients; the Patients with acute pyelonephritis. The baseline concentrations of phospholipids were markedly elevated compared with difference between healthy controls and the patients with acute pyelonephritis; the difference between the two the healthy controls (P<0.0001). There were no differences between the two pyelonephritis groups at baseline, at day 1 treatment groups at the various time points measured. The patients with pyelonephritis were also analysed within or 2-4 weeks post-dosing. However at 3 days the group treated with the single large dose had significantly lower patients, before, during (at 1 and 3 days) and after treatment using Wilcoxon's signed rank test. A level of significance phospholipid excretion than the conventionally treated group (P<0.05) (Figure 2 ). for all tests was set at P<0.05.
A Deming analysis was used to determine the correlation Within group comparisons were made difficult by the non-collection of urine at some time periods, making the coefficient (r 2 ) between the calculated creatinine clearance and urinary phospholipid excretion. A Deming analysis is a sample sizes small. The two groups were therefore combined at baseline, day 1, and 1-2 weeks after treatment, (at which linear least squares analysis that accounts for errors in both X and Y data, as opposed to only considering error in the Y data.
times they were not different from each other). Paired comparisons revealed no difference between baseline and day 1 phospholipid excretion, but there was a significant Results decrease in phospholipid excretion 1-2 weeks after completion of gentamicin therapy compared with baseline Assay (P<0.0001) and 24 h (P=0.03). The standard curve was linear over the range 0.65 to 32.3 mmol l −1 (0.02 to 1 mg l −1 ). The coefficient of Accidental overdose variation of the standard curve varied from 3.3 to 9.4%, with coefficient of determination (r 2 ) ranging from 0.9975 A single urine sample obtained immediately after the last dose of aminoglycoside had a phospholipid concentration of to 0.9992. Complete digestion of PC standard was confirmed 9.07 mmol mol −1 of creatinine, which was considerably higher than the ratio obtained for any other patient. Over the following 2 days, her serum creatinine concentrations increased from 0.05 to 0.10 mmol l −1
. The patient then developed oliguric renal failure, although this may have been associated with her underlying disease, necrotising fasciitis, which ultimately proved fatal.
Discussion

Assay
In the present studies, a method adapted from Folch et al.
[10], and Olier et al. [8] was used to extract the phospholipid from urine, and our recoveries (95%) were consistent with rich phase, it was important to minimise contamination by the interfacial film which contains large amounts of inorganic phosphates. Filtration of the chloroform rich phase is required to remove insoluble phosphates but careful separation of the CHCl 3 rich phase also minimises contamination of the extracts. The difference in the phospholipid concentrations found by centrifugation compared with lyophilisation is important when comparing our results with those of previous researchers [6, 8] . When these differences in methodology are accounted for, all researchers appear to have achieved similar results.
Urinary phospholipids
Three features are of special note. Firstly, there was lipids in the urine of healthy subjects was much lower than in the septicaemic patients and in the patients with acute highlight the necessity to measure phospholipids prior to treatment in order to distinguish drug effect from that due pyelonephritis. Consistent with this was the negative correlation in phospholipid excretion in relation to creatinine to the disease state.
Our results do not assist in recognising which patients are clearance. This implies that phospholipiduria may indeed be a marker of damage to the kidneys, resulting in the decline likely to progress clinically to renal failure. Further work should be directed towards determining if there is a level of in renal function. Thirdly, urinary phospholipid excretion did not alter during treatment with gentamicin in patients urinary phospholipid excretion which is predictive of renal toxicity. Studies in rats indicate that the urinary excretion with acute pyelonephritis but lower concentrations were observed 1 to 2 weeks after treatment had ceased.
of phospholipids increases before creatinine clearance falls [4, 18] , and also 'that a critical threshold in phospholipid Importantly, the reduction in phospholipid excretion began earlier in the patients treated with the single large dose of accumulation needs to be reached before it leads to cell death, whereas keeping below this critical value will allow gentamicin compared with those treated conventionally.
It was difficult to compare our results directly with the the cell to survive, and even to return to its normal state if the drug is withdrawn' [2] . If such a critical threshold can previously published work because of the differences in the aminoglycosides examined, the doses used, the disease states be demonstrated in the urinary concentrations of phospholipids, then measurement of urinary phospholipid concenof the patients and the methods of analysis. It appears, however, that the phospholipid concentrations during trations may well be superior to the measurement of plasma concentrations of creatinine and may anticipate and help treatment with aminoglycosides are similar in all studies when corrected for recoveries related to different methodpre-empt aminoglycoside toxicity. The threshold may however be so high as to make considerations of preologies, but the mean concentrations in the control subjects varied considerably. This is likely to be the result of a treatment phospholipid concentrations irrelevant to the prediction of renal failure, but more detailed clinical different choice of control subjects (healthy versus pretreatment sick) in the various studies.
examination of urinary phospholipid concentrations before, during and after treatment with aminoglycosides is required. The only previous study in which total phospholipid concentrations were measured was that of Olier et al. Ibrahim et al.
[6] lies in the concentrations in the controls.
